2024 annual financial data
CytoMed Therapeutics 2024 Operating margin
Direct answer
Operating margin was -4,504.29%.
Operating income was -3,130,528 SGD and net income was -2,516,698 SGD.
Operating cash flow was -2,709,331 SGD.
Get free CytoMed Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 69,501 SGD
- Operating income
- -3,130,528 SGD
- Net income
- -2,516,698 SGD
- Operating cash flow
- -2,709,331 SGD